Resultados de la implantación del esquema Pembrolizumab-Lenvatinib en carcinoma de endometrio avanzado/metastásico en un hospital de tercer nivel

Diego Ozcoidi Idoate, P González Pérez, B. Matilla Fernández, Juan Carlos Saez Hortelano, Ana Fernández Vázquez, María Barba Llacer, Rubén Varela Fernández, Juan José Ortiz de Urbina González
In: Libro de comunicaciones 70 Congreso SEFH · 2025 · doi:10.62917/25.70.0535 · W4413282040
OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-14 ⓘ

This paper reports outcomes from implementing the Pembrolizumab-Lenvatinib regimen for advanced/metastatic endometrial carcinoma at a tertiary hospital.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

17 al 19 de Octubre del 2024. 70 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria(SEFH). Participa en el evento científico por excelencia en el marco de la Farmacia Hospitalaria en España.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK